Olivier Lambert

Olivier Lambert is the SVP, Head of Global Pharmaceutical Development & Quality Assurance at Idorsia. Olivier has over 20 years of experience in the pharmaceutical industry. Olivier began their career at Novartis in 1998 as a principal scientist in pharmaceutical development. In 2005, they joined Actelion as Head of Quality Assurance_ GMP. Olivier was responsible for supervising the Global Quality Management Department - Quality Assurance (GMP/GDP), writing or reviewing and approving Good Manufacturing Practices and regulatory relevant documents related to quality systems, supporting and/or conducting internal and external audits, and monitoring efficiency of the pharmaceutical quality system (PQS), establishing relevant KPIs, and defining and implementing improvements of the PQS when required. In 2017, Olivier joined Idorsia as SVP, Head of Global Pharmaceutical Development & Quality Assurance.

Olivier Lambert has a PhD in Chemistry from Université de Haute-Alsace Mulhouse-Colmar and a High School diploma from saint sigisbert nancy.

They are on a team with Simon Jose - EVP, Chief Commercial Officer, Andrew C. Weiss - SVP, Head of Investor Relations & Corporate Communications, and Oliver Peinelt - SVP, Group General Counsel. Their manager is Jean-Paul Clozel, CEO.